American Cancer Society. Cancer facts and figures, 1998. New York: American Cancer Society; 1998.
Eddy DM. Screening for colorectal cancer. Ann Intern Med. 1990; 113:373-84.
Wagner JL, Herdman RC, Wadhwa S. Cost effectiveness of colorectal cancer screening in the elderly. Ann Intern Med. 1991; 115:807-17.
Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology. 1995; 109:1781-90.
Eddy DM, Nugent FW, Eddy JF, Coller J, Gilbertsen VV, Gottlieb LS, et al.. Screening for colorectal cancer in a high-risk population. Results of a mathematical model. Gastroenterology. 1987; 92:682-92.
Wagner JL, Tunis S, Brown M, Ching A, Almeida R. Cost-effectiveness of colorectal cancer screening in average-risk adults. Young GP, Rozen P, Levin B Prevention and Early Detection of Colorectal Cancer. London: Saunders; 1996; 321-56.
Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al.. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997; 112:594-642.
Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case–control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992; 326:653-7.
Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al.. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993; 329:1977-81.
Müller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case–control study among veterans. Arch Intern Med. 1995; 155:1741-8.
Müller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy. A case–control study of 32,702 veterans. Ann Intern Med. 1995; 123:904-10.
Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993; 13:322-38.
U.S. Decennial Life Tables for 1989-91. Vol 1, No 1. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 1997. DHHS Publication No. PHS-98-1150-1.
Ahlquist DA. Occult blood screening. Obstacles to effectiveness. Cancer. 1992; 70:1259-65.
Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med. 1996; 334:155-9.
Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut. 1982; 23:835-42.
Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer. 1982; 49:819-25.
Shinya Y, Wolff WI. Morphology, anatomic distribution and cancer potential of colonic polyps. Ann Surg. 1979; 190:679-83.
Kirschner CG, Davis SJ, Evans D, Hayden D, Jackson JA, Jacobson CA, et al.. Current Procedural Terminology: CPT. Chicago: American Medical Assoc; 1999.
Seare S, Speirs L, Bernard SP, Turner K, Neeshan C. DRG Guide. Salt Lake City: Medicode; 1997.
Garbay JR, Suc B, Rotman N, Fourtanier G, Escat J. Multicentre study of surgical complications of colonoscopy. Br J Surg. 1996; 83:42-4.
Vukasin AP, Ballantyne GH, Flannery JT, Lerner E, Modlin IM. Increasing incidence of cecal and sigmoid carcinoma. Data from the Connecticut Tumor Registry. Cancer. 1990; 66:2442-9.
Provenzale D, Wong JB, Onken JE, Lipscomb J. Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis. Am J Gastroenterol. 1998; 93:872-80.
Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al.. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996; 348:1472-7.
Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, et al.. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA. 1993; 269:1262-7.
Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a group practice setting. Ann Intern Med. 1990; 112:328-33.
Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer. 1988; 62:645-51.
Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med. 1997; 126:811-22.
Kronborg O, Fenger C, Olsen J, Jorgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996; 348:1467-71.
Kronborg O, Fenger C, Olsen J, Bech K, Søndergaard O. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol. 1989; 24:599-606.
Bat L, Pines A, Ron E, Niv Y, Arditi E, Shemesh E. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance. Am J Gastroenterol. 1986; 81:647-51.
Brevinge H, Lindholm E, Buntzen S, Kewenter J. Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55-56 years' old population. Int J Colorectal Dis. 1997; 12:291-5.
Riff ER, Dehaan K, Garewal GS. The role of sigmoidoscopy for asymptomatic patients. Results of three annual screening sigmoidoscopies, polypectomy, and subsequent surveillance colonoscopy in a primary-care setting. Cleve Clin J Med. 1990; 57:131-6.
Wallace MB, Kemp JA, Trnka YM, Donovan JM, Farraye FA. Is colonoscopy indicated for small adenomas found by screening flexible sigmoidoscopy? Ann Intern Med. 1998; 129:273-8.
Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol. 1991; 86:946-51.
Ries LA, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1994. Bethesda, MD: National Institutes of Health, National Cancer Institute; 1997. NIH Publication No. 97-2789.
Towler B, Irwing L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ. 1998; 317:559-66.
Hart R, Classen M. Complications of diagnostic gastrointestinal endoscopy. Endoscopy. 1990; 22:229-33.
Waye JD, Lewis BS, Yessayan S. Colonoscopy: a prospective report of complications. J Clin Gastroenterol. 1992; 15:347-51.
Puchner R, Allinger S, Doblhofer F, Wallner M, Knoflach P. [Complications of diagnostic and interventional colonoscopy]. Wien Klin Wochenschr. 1996; 108:142-6.
Waye JD, Kahn O, Auerbach ME. Complications of colonoscopy and flexible sigmoidoscopy. Gastrointest Endosc Clin N Am. 1996; 6:343-77.
Van Gossum A, Cozzoli A, Adler M, Taton G, Cremer M. Colonoscopic snare polypectomy: analysis of 1485 resections comparing two types of current. Gastrointest Endosc. 1992; 38:472-5.
Singaram C, Torbey CF, Jacoby RF. Delayed postpolypectomy bleeding. Am J Gastroenterol. 1995; 90:146-7.
Lee JG, Vigil HT, Leung JW. The hospital costs for diagnosis and treatment of colorectal cancer [Abstract]. Gastrointest Endosc. 1999; 49:AB145.
Weinstein MC, Stason WB. Foundations of cost-effectiveness for health and medical practices. N Engl J Med. 1977; 296:716-21.
Siegel JE, Weinstein MC, Torrance GW. Reporting cost-effectiveness studies and results. Gold MR, Siegel JE, Russel LB, Weinstein MC Cost-Effectiveness in Health and Medicine. New York: Oxford Univ Pr; 1996; 276-303.
Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Cost-effectiveness analysis. In: Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. New York: Oxford Univ Pr; 1997:96-138.
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al.. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993; 328:1365-71.
Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer. A case–control study. Ann Intern Med. 1993; 118:1-6.
Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992; 84:1572-5.
Rex DK, Lehman GA, Hawes RH, Ulbright TM, Smith JJ. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology. 1991; 100:64-7.
Rules and regulations. Fed Regist. 1997; 211.